SCHEMBL1635670

SCHEMBL1635670

COc1cc(OC)c(C=CC(=O)Nc2ccc(OC)c(-c3cc(N4CCN(C)CC4)ccc3C(=O)O)c2)c(OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 9/20 0.47
HTR1D P28221 9/20 0.47
HTR1B P28222 9/20 0.47
KMT2A Q03164 6/20 0.45
MEN1 O00255 3/20 0.45
MAPT P10636 6/20 0.43
NPC1 O15118 4/20 0.43
RAB9A P51151 3/20 0.43
TP53 P04637 2/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
POLB P06746 3/20 0.43
KDM4E B2RXH2 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
HTR2A P28223 3/20 0.42
HTR2C P28335 2/20 0.42
HTR6 P50406 2/20 0.42
ABCB1 P08183 1/20 0.42
LMNA P02545 2/20 0.41
ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1635800 0.86 HTR1A (0.41) HTR1AHTR1DHTR1BKMT2AMAPT
SCHEMBL1636578 0.82 KDM1A (0.45) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL4204532 0.79 NPC1 (0.56) HTR1AHTR1DHTR1BKMT2AMEN1
SCHEMBL1635661 0.79 NPC1 (0.53) HTR1AHTR1DHTR1BKMT2AMEN1
SCHEMBL4204536 0.79 NPC1 (0.56) HTR1AHTR1DHTR1BKMT2AMEN1
SCHEMBL1636454 0.79 KMT2A (0.48) KMT2AMEN1MAPTNPC1RAB9A
SCHEMBL1636200 0.79 PLK1 (0.51) HTR1AHTR1DHTR1BKMT2AMAPT
SCHEMBL5506837 0.77 HTR1A (0.47) HTR1AHTR1DHTR1BKMT2AMEN1
SCHEMBL1635666 0.77 BRPF1 (0.46) HTR1AHTR1DHTR1BKMT2AMEN1
SCHEMBL4657749 0.74 MEN1 (0.43) HTR1AHTR1DHTR1BKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3138832-A1 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University - Of The Commonwealth System of Higher Education (US) 2017-03-08 EP claimed
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2008-03-06 US claimed
EP-1740530-A4 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS UNIV TEMPLE (US) 2008-02-27 EP claimed
JP-2007529530-A 2007-10-25 JP claimed
EP-1740530-A2 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University of the Commonwealth System of Higher Education (US) 2007-01-10 EP claimed
WO-2005089269-A2 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2005-09-29 WO claimed
US-7932242-B2 Anticancer agents; radiation and chemical resistance TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-04-26 US disclosed
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2008-03-06 US disclosed
EP-1740530-A4 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS UNIV TEMPLE (US) 2008-02-27 EP disclosed
EP-1740530-A2 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University of the Commonwealth System of Higher Education (US) 2007-01-10 EP disclosed
WO-2005089269-A2 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2005-09-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders PCNA, MKI67, TP53 HTR1A 2323/4885HTR1D 3453/4885HTR1B 2983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.